
The adoption of M&S to the pharma industry has been slow, but more noticeable in recent years as these practices have improved the efficiency of drug development processes.
The adoption of M&S to the pharma industry has been slow, but more noticeable in recent years as these practices have improved the efficiency of drug development processes.
IntrinsiQ Specialty Solutions and ION Solutions, both of AmerisourceBergen, have announced the launch of AdvanceIQ Network.
PAREXEL has launched a mobile app for its ClinPhone randomization and trial supply management service.
ProTrials Research has announced the expansion of their clinical suite to include data management services.
As pharma continues to struggle with designing studies that result in creating breakthrough medical therapies, biopharma sponsors focusing on CNS studies face similar challenges and risks.
The Association of Clinical Research Professionals has released a harmonized Core Competency Framework for Clinical Research Associates that defines core competencies.
ERT has launched its refreshed eCOA technology environment, with enhanced features on the back-end to make eCOA easier for patients to use, and more cost effective and faster for sponsors to implement.
The latest version of the Prescription Drug User Fee Act has sponsors and FDA officials pressing for Congressional action regarding the program’s provisions accelerating the drug development and application review processes.
Veeva Systems announced the future release of Veeva Vault Submissions Publishing, a cloud application that incorporates publishing capabilities within Veeva Vault RIM to speed regulatory submission delivery.
Montrium announced the release of the Regulatory Navigator, an interactive intelligence dashboard integrated into the company’s RegDocs Connect, a Regulatory EDMS solution.
The war on cancer has seen significant strides made in the search for a cure, however, recent data suggests that the work is far from over.
When designing and using an electronic informed consent form, there are many factors that should be considered when applying to clinical research.
Almac Group has announced the launch of their temperature management software TempEZ, the first offering from Almac’s “Next Generation Temperature Management Portfolio”.
PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries.
The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.
OmniComm Systems and MediStat have collaborated to expand their life sciences market presence in Israel.
Study finds that financial links between researchers and drug manufacturers are independently associated with positive trial results.
Q&A explores the evolution and challenges of new technology implementation in clinical trials.
Recent studies may help break down barriers to implementing patient-centric initiatives.